Lymphocyte subsets show different response patterns to in vivo bound natalizumab--a flow cytometric study on patients with multiple sclerosis.

Andrea Harrer* (First author), Georg Pilz (First author), Max Einhaeupl, Katrin Oppermann (Co-author), Wolfgang Hitzl (Co-author), Peter Wipfler (Co-author), Johann Sellner (Co-author), Stefan Golaszewski (Co-author), Shahrzad Afazel, Elisabeth Haschke-Becher (Co-author), Eugen Trinka (Co-author), Jörg Kraus (Last author)

*Corresponding author for this work

Research output: Contribution to journalOriginal Article (Journal)peer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)e31784
JournalPLOS ONE
Volume7
Issue number2
DOIs
Publication statusPublished - 2012

Keywords

  • NATURAL-KILLER-CELLS
  • PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
  • PERIPHERAL-BLOOD
  • CEREBROSPINAL-FLUID
  • ADHESION MOLECULES
  • MONONUCLEAR-CELLS
  • CONTROLLED TRIAL
  • INTERFERON-BETA
  • EXPRESSION
  • MS

Cite this